Discontinued
PREVENAR 13 pneumococcal polysaccharide conjugate vaccine 13 valent adsorbed 0.5 mL syringe
Pneumococcal purified capsular polysaccharides~Pneumococcal purified capsular polysaccharides · 4.4 microgram~2.2 microgram Injection, suspension
- Deletion from market
- 30 June 2026
- TGA row last updated
- 25 May 2026
- ARTG ID
- 158450
- Sponsor
- Pfizer Australia Pty Ltd
- Sponsor phone
- 1800675229
- Shortage impact
- Low
- Availability
- Reduction in supply until supply is exhausted
Reason reported to TGA
Commercial Changes / Commercial viability
TGA management action
This product will be replaced by Prevenar 20 pneumococcal polysaccharide conjugate vaccine (ARTG 376353)
What to do
- 1.This product is discontinued in the TGA export — Ask your prescriber or pharmacist about a product that is still supplied. Do not stop treatment without that advice.
Official sources
Last updated from the TGA Medicine Shortage Reports Database (report generated 12 November 2026 10:15:07 PM).
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.